| URL | https://www.pharmtech.com/view/agc-biologics-adds- |
| Source | Pharmtech.com |
| Date Published | 05/26/2022 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | AGC Biologics |
| Parent company | AGC Inc |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 30 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Longmont |
| State(s) reshored to: | CO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | gene therapies |